DE2206785A1 - Mittel zur magensaftsekretionshemmung und ulcusbehandlung - Google Patents

Mittel zur magensaftsekretionshemmung und ulcusbehandlung

Info

Publication number
DE2206785A1
DE2206785A1 DE2206785A DE2206785A DE2206785A1 DE 2206785 A1 DE2206785 A1 DE 2206785A1 DE 2206785 A DE2206785 A DE 2206785A DE 2206785 A DE2206785 A DE 2206785A DE 2206785 A1 DE2206785 A1 DE 2206785A1
Authority
DE
Germany
Prior art keywords
inhibition
agent
juice
giomatic
ulcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2206785A
Other languages
German (de)
English (en)
Inventor
Wilhelm Dr Konz
Franz Prof Waldeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ZA730923A priority Critical patent/ZA73923B/xx
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Priority to DE2206785A priority patent/DE2206785A1/de
Priority to US00330183A priority patent/US3818091A/en
Priority to NL7301767A priority patent/NL7301767A/xx
Priority to IL41513A priority patent/IL41513A0/xx
Priority to FR7304857A priority patent/FR2181723B1/fr
Priority to BE795327D priority patent/BE795327A/xx
Priority to AU52078/73A priority patent/AU5207873A/en
Publication of DE2206785A1 publication Critical patent/DE2206785A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE2206785A 1972-02-12 1972-02-12 Mittel zur magensaftsekretionshemmung und ulcusbehandlung Pending DE2206785A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ZA730923A ZA73923B (en) 1972-02-12 1972-02-09 Agent for inhibition of gastric fluid secretion and treatment of ulcus
DE2206785A DE2206785A1 (de) 1972-02-12 1972-02-12 Mittel zur magensaftsekretionshemmung und ulcusbehandlung
US00330183A US3818091A (en) 1972-02-12 1973-02-07 Pharmaceutical compositions containing a lpha-pheny-alpha-pyridyl-acetonitrile and method of use
NL7301767A NL7301767A (enExample) 1972-02-12 1973-02-08
IL41513A IL41513A0 (en) 1972-02-12 1973-02-09 Pharmaceutical compositions containing a derivatives of pyridine
FR7304857A FR2181723B1 (enExample) 1972-02-12 1973-02-12
BE795327D BE795327A (fr) 1972-02-12 1973-02-12 Produit pour l'inhibition de la secretion du suc gastrique et pour le traitement des ulceres
AU52078/73A AU5207873A (en) 1972-02-12 1973-02-12 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2206785A DE2206785A1 (de) 1972-02-12 1972-02-12 Mittel zur magensaftsekretionshemmung und ulcusbehandlung

Publications (1)

Publication Number Publication Date
DE2206785A1 true DE2206785A1 (de) 1973-08-16

Family

ID=5835867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2206785A Pending DE2206785A1 (de) 1972-02-12 1972-02-12 Mittel zur magensaftsekretionshemmung und ulcusbehandlung

Country Status (8)

Country Link
US (1) US3818091A (enExample)
AU (1) AU5207873A (enExample)
BE (1) BE795327A (enExample)
DE (1) DE2206785A1 (enExample)
FR (1) FR2181723B1 (enExample)
IL (1) IL41513A0 (enExample)
NL (1) NL7301767A (enExample)
ZA (1) ZA73923B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373222A (en) * 1980-01-28 1983-02-15 Enhancement Systems, Inc. Prosthetic bench

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507631A (en) * 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
GB589625A (en) * 1944-01-19 1947-06-25 Chem Ind Basel Manufacture of new pyridine and piperidine compounds
US3225054A (en) * 1962-07-03 1965-12-21 Searle & Co 4-dipropylamino-2-aryl-2-pyridylalkanamides

Also Published As

Publication number Publication date
AU5207873A (en) 1974-08-15
FR2181723A1 (enExample) 1973-12-07
NL7301767A (enExample) 1973-08-14
BE795327A (fr) 1973-08-13
ZA73923B (en) 1974-10-30
US3818091A (en) 1974-06-18
IL41513A0 (en) 1973-05-31
FR2181723B1 (enExample) 1976-07-02

Similar Documents

Publication Publication Date Title
DE2856393A1 (de) Mittel zur behandlung des zentralnervensystems
DE3855323T2 (de) Galenische 2-beta-Mimetik-Formen für die per- und sublinguale Verabreichung
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE3319282C2 (enExample)
DE69125940T2 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
EP1019055B1 (de) Endothelin antagonist und betarezeptorenblocker als kombinationspräparate
EP0132595B1 (de) Tokolytisches Mittel
EP0381303A1 (de) Verwendung von Suramin und physiologisch verträglichen Derivaten davon, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Herstellung von Arzneimitteln zur Behandlung des humanen Prostatakarzinoms
DE3315482A1 (de) Mittel zur verhinderung und behandlung von blutlipid-abnormalitaet und/oder arteriosclerose
EP0301373B1 (de) Erzeugnisse, enthaltend Gallopamil und Prazosin
EP0013252B1 (de) Mittel zur Senkung der Herzfrequenz
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2937489A1 (de) Arzneimittel zur behandlung hypertoner funktionszustaende der harnblase
DE2342214C3 (de) Heilmittel
DE3407509A1 (de) Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen
DE3887426T2 (de) Eperisone als Hypotonikum.
DE3305690A1 (de) Glycerinmononitrate zur behandlung der angina pectoris
DE2157201B2 (de) Verbesserte feste orale Applikationsform von Raubasin
DE2638554A1 (de) Choleretika
CH644374A5 (en) Water-soluble hydroxyflavone ethers and medicaments containing them
AT330953B (de) Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
DE2055930A1 (de) Verbesserte orale Applikationsform von Raubasin
DE1792271C3 (de) Blutdrucksenkendes Arzneimittel
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
DE2337202C2 (de) Arzneimittel, enthaltend Vincamin und Rutin